Chromadex Corp
NASDAQ:CDXC
Chromadex Corp
NASDAQ:CDXC
Price:
3.78 USD
0.53%
Market Closed
Updated:
May 5, 2024
Chromadex Corp
Cost of Revenue
|
Chromadex Corp
Cost of Revenue Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Chromadex Corp
NASDAQ:CDXC
|
Cost of Revenue
-$32.8m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-17%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cost of Revenue
-$25.8B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-13%
|
|
|
Danaher Corp
NYSE:DHR
|
Cost of Revenue
-$18.2B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-7%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cost of Revenue
-$1.5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-3%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Cost of Revenue
-$3.3B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cost of Revenue
-$9.7B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-10%
|
See Also
What is Chromadex Corp's Cost of Revenue?
Cost of Revenue
-32.8m
USD
-32.8m
USD
Based on the financial report for Dec 31, 2023, Chromadex Corp's Cost of Revenue amounts to -32.8m USD.
What is Chromadex Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-17%
-17%
Over the last year, the Cost of Revenue growth was -12%. The average annual Cost of Revenue growth rates for Chromadex Corp have been -11% over the past three years , -16% over the past five years , and -17% over the past ten years .
You don't have any saved screeners yet
